申请人:SMITH KLINE & FRENCH LABORATORIES
LIMITED
公开号:EP0403271A3
公开(公告)日:1992-02-12
Polymers of structure (I)
in which X is a co-monomer unit; X1 is a cross-linking unit; R1 is a saturated or unsaturated C6 to C20 alkyl group; R2 and R3 are the same or different and are each C1 -4alkyl; Y - is a physiologically acceptable counter ion; and a, b and c are numbers which indicate the relative molar percentages of the units present in a random distribution in said polymer, (b) being from about 0.5 to about 10 molar percent and (c) being from about 30 to about 99 molar percent, processes for their prepapration, pharmaceutical compositions containing them, and their use in therapy as cholesterol lowering agents.
结构式(I)的聚合物中,其中X是共聚单元; X1是交联单元; R1是饱和或不饱和的C6至C20烷基基团; R2和R3相同或不同,均为C1-4烷基; Y-是生理上可接受的反离子; a、b和c是数字,表示在所述聚合物中存在的单元的相对摩尔百分比,其中(b)为约0.5至约10摩尔百分比,(c)为约30至约99摩尔百分比,其制备方法、含有它们的制药组合物以及它们作为降低胆固醇药物的治疗用途。